BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21859943)

  • 1. Transmission of dapsone-resistant leprosy detected by molecular epidemiological approaches.
    Li W; Sakamuri RM; Lyons DE; Orcullo FM; Shinde V; Dela Pena EL; Maghanoy AA; Mallari IB; Tan EV; Nath I; Brennan PJ; Balagon M; Vissa V
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5384-7. PubMed ID: 21859943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
    Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of rifampin and dapsone resistance in three patients with recurring leprosy].
    Hernández E; Cardona-Castro N; Rodríguez G; Villegas S; Beltrán C; Kimura M; Vissa VD; Gómez Y
    Rev Panam Salud Publica; 2008 Feb; 23(2):73-7. PubMed ID: 18371276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
    Williams DL; Araujo S; Stryjewska BM; Scollard D
    Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
    Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
    Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.
    Cambau E; Saunderson P; Matsuoka M; Cole ST; Kai M; Suffys P; Rosa PS; Williams D; Gupta UD; Lavania M; Cardona-Castro N; Miyamoto Y; Hagge D; Srikantam A; Hongseng W; Indropo A; Vissa V; Johnson RC; Cauchoix B; Pannikar VK; Cooreman EAWD; Pemmaraju VRR; Gillini L;
    Clin Microbiol Infect; 2018 Dec; 24(12):1305-1310. PubMed ID: 29496597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
    Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
    Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.
    Li X; Li G; Yang J; Jin G; Shao Y; Li Y; Wei P; Zhang L
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
    Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
    Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
    Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
    Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.
    Vedithi SC; Malhotra S; Das M; Daniel S; Kishore N; George A; Arumugam S; Rajan L; Ebenezer M; Ascher DB; Arnold E; Blundell TL
    Sci Rep; 2018 Mar; 8(1):5016. PubMed ID: 29567948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance.
    Nakata N; Kai M; Makino M
    Antimicrob Agents Chemother; 2011 Feb; 55(2):762-6. PubMed ID: 21115799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
    Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
    Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistant Mycobacterium leprae from patients with leprosy.
    Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for
    Mahajan NP; Lavania M; Singh I; Nashi S; Preethish-Kumar V; Vengalil S; Polavarapu K; Pradeep-Chandra-Reddy C; Keerthipriya M; Mahadevan A; Yasha TC; Nandeesh BN; Gnanakumar K; Parry GJ; Sengupta U; Nalini A
    Am J Trop Med Hyg; 2020 Mar; 102(3):547-552. PubMed ID: 31933458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen.
    Chhabra S; Narang T; Sahu S; Sharma K; Shilpa S; Sharma A; Jain S; Singh I; Yadav R; Kaur M; Sharma R; Nadeem M; Pandey P; Minz RW; Dogra S
    J Glob Antimicrob Resist; 2023 Dec; 35():262-267. PubMed ID: 37852372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
    Andrade ESN; Brandão JG; Silva JSD; Coriolano CRF; Rosa PS; Moraes MO; Ferreira CO; Gomes CM; Araújo WN
    Antimicrob Agents Chemother; 2022 May; 66(5):e0217021. PubMed ID: 35435708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy.
    Soares DJ; Neupane K; Britton WJ
    Lepr Rev; 1995 Sep; 66(3):210-3. PubMed ID: 7500815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
    Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
    Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.